|
Gestational Age (weeks) |
Source |
34 |
35 |
36 |
37 |
38 |
39 |
Emergent Bleed |
0.0000 |
0.0469 |
0.1504 |
0.2987 |
0.5855 |
0.8723 |
Calculated, see text Zlatnik 2007(6) |
Intrauterine fetal demise |
0.0000 |
0.0004 |
0.0007 |
0.0012 |
0.0017 |
0.0022 |
Smith 2000(7) |
Neonatal death |
0.0130 |
0.0080 |
0.0050 |
0.0044 |
0.0029 |
0.0020 |
Copper 1993 (8), see text |
Respiratory distress syndrome |
0.1350 |
0.0640 |
0.0330 |
0.0040 |
0.0040 |
0.0030 |
Robertson 1992(9) |
Cerebral palsy |
0.0088 |
0.0051 |
0.0031 |
0.0025 |
0.0013 |
0.0009 |
Surman 2004(10) |
|
|
No emergent bleed |
Emergent bleed |
Kohi P, Zlatnik M, Little S, Caughey A. Bleeding previa: what are the risks? [abstract] Am J Obstet Gynecol 2006;195S113. |
Postpartum hemorrhage |
0.124 |
0.2488 |
Blood transfusion |
0.0849 |
0.2615 |
Hysterectomy |
0.0165 |
0.0547 |
|
No placenta accreta |
Placenta accreta |
|
Maternal death, if hysterectomy |
0.01 |
0.091 |
Gielchinsky (11), Clark 1984(12) |
Placenta accreta |
0.05 |
Usta 2005(13), Miller 1997(14) |
Amniocentesis rupture of membranes |
0.01 |
Gordon 2002(15) |
Reduction in respiratory distress syndrome from steroid administration |
0.34 |
Roberts 2006(16), Stutchfield 2005 (17) |
% of cerebral palsy that is severe |
0.29 |
Surman 2004(10) |
% of cerebral palsy that is moderate |
0.15 |
Sensitivity fetal lung maturity testing |
0.851 |
Herbert 1986(18) |
Specificity fetal lung maturity testing |
0.843 |
Life expectancies |
Maternal |
56 |
CDC(19) |
Neonatal |
77.9 |
Neonate with severe cerebral palsy |
28.7 |
Life Expectancy Project 2005(20) |
Neonate with moderate cerebral palsy |
62 |
Utilities |
Infertility |
0.82 |
Hu 2004(21) |
Having a child with cerebral palsy |
0.81 |
Kuppermann 2000(22) |
Fetal/Neonatal death |
0.92 |
Having severe cerebral palsy |
0.3 |
Saigal 1999(23) |
Having moderate cerebral palsy |
0.9 |
Having a child with respiratory distress |
0.98 (one year duration) |
Assumed |